Drug induced Liver Injury (Panopto Video Link) Flashcards

1
Q

How many drugs have been implicated in causing liver disease on more than one occasion?

A

Thousands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is perhexiline now available on the market despite being associated with serious liver toxicity?

A

Toxicity is associated with supratherapeutic levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are 10 drugs which have been withdrawn due to serious liver toxicity?

A
  1. Ximelagatran
  2. Troglitazone
  3. Benoxaprofen
  4. Perhexiline (now available)
  5. Bromofenac
  6. Felbamate
  7. Pemoline
  8. Tolcapone
  9. Nafazadone
  10. Trovafloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is perhexiline now available on the market despite being associated with serious liver toxicity?

A

Toxicity is associated with supratherapeutic levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the relationship between LFT derangement and drug-induced liver injury?

A

There is not always a link between drug-induced liver injury and LFT derangement (i.e. DILI can be idiosyncratic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 9 drugs where LFTs should be routinely monitored?

A
  1. Statins
  2. Carbamazepine
  3. Valproate
  4. Methotrexate
  5. Leflunomide
  6. Flucloxacillin
  7. Clavulanic acid
  8. Amiodarone
  9. Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 9 drugs where LFTs should be routinely monitored?

A
  1. Statins
  2. Carbamazepine
  3. Valproate
  4. Methotrexate
  5. Leflunomide
  6. Flucloxacillin
  7. Clavulanic acid
  8. Amiodarone
  9. Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 9 drugs where LFTs should be routinely monitored?

A
  1. Statins
  2. Carbamazepine
  3. Valproate
  4. Methotrexate
  5. Leflunomide
  6. Flucloxacillin
  7. Clavulanic acid
  8. Amiodarone
  9. Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 9 drugs where LFTs should be routinely monitored?

A
  1. Statins
  2. Carbamazepine
  3. Valproate
  4. Methotrexate
  5. Leflunomide
  6. Flucloxacillin
  7. Clavulanic acid
  8. Amiodarone
  9. Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are 9 drugs where LFTs should be routinely monitored?

A
  1. Statins
  2. Carbamazepine
  3. Valproate
  4. Methotrexate
  5. Leflunomide
  6. Flucloxacillin
  7. Clavulanic acid
  8. Amiodarone
  9. Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the typical pattern of LFT derangement seen with statins?

A

Transaminitis (i.e. AST and ALT are elevated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why are statins thought to cause transaminitis (AST and ALT elevation)?

A

It is thought to be more a result of the pharmacodynamic effect of lipid lowering, which can alter the composition of the membrane of hepatocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How common are ALT levels > 3 times the upper limit of normal on > 2 measurements with statins?

A

This is dose-related and generally less than 3% in incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How common are ALT levels > 3 times the upper limit of normal on > 2 measurements with statins?

A

This is dose-related and generally less than 3% in incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the estimated incidence of fulminant liver failure attributable to lovastatin?

A

2 in one million patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the estimated incidence of fulminant liver failure attributable to lovastatin?

A

2 in one million patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the incidence of statin-associated liver failure estimated to be?

A

1 per million person-years of use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are 10 drugs associated with DRESS syndrome?

A
  1. Aromatic antiepileptics (phenytoin, carbamazepine,
    oxcarbazepine and the barbiturates)
  2. Lamotrigine
  3. sulfonamide antibacterials
  4. dapsone
  5. minocycline
  6. azathioprine
  7. abacavir
  8. nevirapine
  9. allopurinol
  10. strontium ranelate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are 3 options when a patient presents with statin-induced transaminitis?

A
  1. Reduce the dose
  2. Change the statin
  3. Ignore the transaminitis as it may not lead to functional issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When do we usually consider reducing the dose of a statin as a result of LFT derangement?

A

When transaminases rise to around three times the upper limit of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is Hy’s law for drug-induced hepatotoxicity?

A

If hepatocellular injury and jaundice occur concurrently (i.e. elevation of transaminases and bilirubin together), the risk of mortality is at least 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the FDA clinical Trial discontinuation thresholds for LFT derangement?

A
  1. ALT or AST >8 × ULN
  2. ALT or AST >5 × ULN for more than 2 weeks
  3. ALT or AST >3 × ULN and (TBL >2 × ULN or INR >1.5)
  4. ALT or AST > 3 × ULN with the appearance of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia (>5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What does TBL stand for?

A

Total bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What does TBL stand for?

A

Total bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the symptoms of fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, and/or eosinophilia indicative of?

A

DRESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What does DRESS stand for?

A

Drug rash with eosinophilia and systemic symptoms

39
Q

What is the concening pattern of liver injury observed with methotrexate?

A

Hepatic fibrosis and cirrhosis

40
Q

What are 10 drugs associated with DRESS syndrome?

A
  1. Aromatic antiepileptics (phenytoin, carbamazepine,
    oxcarbazepine and the barbiturates)
  2. Lamotrigine
  3. sulfonamide antibacterials
  4. dapsone
  5. minocycline
  6. azathioprine
  7. abacavir
  8. nevirapine
  9. allopurinol
  10. strontium ranelate
41
Q

What are 4 aromatic antiepileptics?

A
  1. Phenytoin
  2. Carbamazepine
  3. Oxcarbazepine
  4. Barbiturates
42
Q

What is a common, but less problematic presentation of methotrexate-induced liver toxicity?

A

There is a frequency asymptomatic transient rise in serum transaminases in 30 to 80% of patients after the start of treatment

43
Q

What is the concening pattern of liver injury observed with methotrexate?

A

Hepatic fibrosis and cirrhosis

44
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
45
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
46
Q

What is a common, but less problematic presentation of methotrexate-induced liver toxicity?

A

There is a frequency asymptomatic transient rise in serum transaminases in 30 to 80% of patients after the start of treatment

47
Q

In which patients are we most concerned about the potential for methotrexate-induced hepatic fibrosis and cirrhosis?

A

In patients on long-term therapy (especially with cumulative doses > 1.5 grams)

48
Q

How does autoimmune hepatitis induced by minocycline typically present?

A

It is associated with lupus-like symptoms, usually after a year or more of exposure to minocycline

49
Q

If a patient has a cumulative dose of methotrexate of over 1.5 grams and is showing signs of liver toxicity, what should you do?

A

Take a liver biopsy

50
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
51
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
52
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
53
Q

What are 6 factors which predispose a patient to methotrexate-associated liver toxicity?

A
  1. Genetic factors
  2. Alcohol excess
  3. Chronic viral hepatitis
  4. Renal insufficiency
  5. Diabetes
  6. Concurrent NSAID use
54
Q

What are two protective factors against methotrexate-induced liver injury?

A
  1. concurrent folate supplementation
  2. concurrent hydroxychloroquine use
55
Q

How does DRESS induced by minocycline typically present?

A

As a hypersensitivity reaction associated with eosinophilia and exfoliative dermatitis, usually occurring within the first 35 days of therapy

56
Q

When does the rare, fatal hepatic failure associated with valproate tend to occur?

A

Within the first three months of therapy

57
Q

When does the rare, fatal hepatic failure associated with valproate tend to occur?

A

Within the first three months of therapy

58
Q

What should you always consider regarding transaminases in patients taking methotrexate?

A

Persistently high abnormal transaminases could be potential indicators of methotrexate toxicity

59
Q

What are 3 forms of liver toxicity which can be caused by minocycline?

A
  1. Acute hepatitis
  2. Autoimmune hepatitis
  3. DRESS
60
Q

How does acute hepatitis induced by minocycline typically present?

A

As a hepatocellular pattern of liver injury, typically 1 to 3 months after starting therapy

61
Q

What are two protective factors against methotrexate-induced liver injury?

A
  1. concurrent folate supplementation
  2. concurrent hydroxychloroquine use
62
Q

What is a concern regarding valproate related to the liver besides LFT derangement?

A

Valproate can cause an asymptomatic rise in ammonia levels - these can rise to above therapeutic range without causing hepatic encephalopathy

63
Q

What are 3 forms of liver toxicity which can be caused by minocycline?

A
  1. Acute hepatitis
  2. Autoimmune hepatitis
  3. DRESS
64
Q

How does acute hepatitis induced by minocycline typically present?

A

As a hepatocellular pattern of liver injury, typically 1 to 3 months after starting therapy

65
Q

How does acute hepatitis induced by minocycline typically present?

A

As a hepatocellular pattern of liver injury, typically 1 to 3 months after starting therapy

66
Q

Describe the prognosis of acute hepatitis induced by minocycline

A

It is usually self-limiting

67
Q

How does autoimmune hepatitis induced by minocycline typically present?

A

It is associated with lupus-like symptoms, usually after a year or more of exposure to minocycline

68
Q

How does DRESS induced by minocycline typically present?

A

As a hypersensitivity reaction associated with eosinophilia and exfoliative dermatitis, usually occurring within the first 35 days of therapy

69
Q

What forms of liver damage has black cohosh been linked with?

A

Hepatitis, liver failure, LFT derangement and various other injuries

70
Q

What is an inherent risk associated with herbal and natural products?

A

Due to their less rigorous testing, they are more prone to adulterants/contaminants

71
Q

What is the consistent factor in all liver injury caused by minocycline?

A

It is always a hepatocellular pattern

72
Q

What is the consistent factor in all liver injury caused by minocycline?

A

It is always a hepatocellular pattern

73
Q

Describe the prognosis of acute hepatitis induced by minocycline

A

It is usually self-limiting

74
Q

What is the primary pattern of liver injury seen with valproate?

A

Transient, asymptomatic, dose-related hepatocellular LFT derangement

75
Q

Can minocycline liver toxicity be fatal?

A

Yes

76
Q

What is the primary pattern of liver injury seen with valproate?

A

Transient, asymptomatic, dose-related hepatocellular LFT derangement

77
Q

What should you do if you see LFT derangement with valproate?

A

In an adult patient, if derangement is mild (i.e. not exceeding Hy’s law), you don’t need to do anything, but in a child under 2 years with severe derangement (particularly if they are on other antiepileptics), you should panic

78
Q

What is a rare but serious liver-related toxicity associated with valproate?

A

Valproate is associated with rare fatal hepatic failure

79
Q

When does the rare, fatal hepatic failure associated with valproate tend to occur?

A

Within the first three months of therapy

80
Q

Which cohort of patients are most predisposed to serious liver toxicity with valproate?

A

Children < 2 years, and patients taking multiple anticonvulsants

81
Q

What should you do if you see LFT derangement with valproate?

A

In an adult patient, if derangement is mild (i.e. not exceeding Hy’s law), you don’t need to do anything, but in a child under 2 years with severe derangement (particularly if they are on other antiepileptics), you should panic

82
Q

What is the expected mechanism by which valproate causes liver toxicity?

A

It is thought to be related to carnitine deficiency

83
Q

What should you do if you see LFT derangement with valproate?

A

In an adult patient, if derangement is mild (i.e. not exceeding Hy’s law), you don’t need to do anything, but in a child under 2 years with severe derangement (particularly if they are on other antiepileptics), you should panic

84
Q

What is a concern regarding valproate related to the liver besides LFT derangement?

A

Valproate can cause an asymptomatic rise in ammonia levels - these can rise to above therapeutic range without causing hepatic encephalopathy

85
Q

Is phosphorus mostly intrinsically toxic to the liver, or dependent on patient factors?

A

It is intrinsically toxic to the liver

86
Q

Is phenytoin mostly intrinsically toxic to the liver, or dependent on patient factors?

A

It is dependent on patient factors

87
Q

Are penicillins mostly intrinsically toxic to the liver, or dependent on patient factors?

A

They are mostly dependent on patient factors

88
Q

What is the incidence of drug-induced liver injury?

A

It ranges from 1 in 10,000 to 1 in 100,000

89
Q

What is the incidence of drug-induced liver injury?

A

It ranges from 1 in 10,000 to 1 in 100,000

90
Q

How many patients are typically involved in clinical phase III study?

A

Between 2,000 and 5,000

91
Q

What is a limitation with clinical trials in their ability to detect drug-induced liver injury?

A

In order for a single case of DILI to be detected in a clinical trial, the drug would have to have a three times greater risk of DILI than most drugs associated with causing DILI

92
Q

Do CAMs have the potential to cause DILI?

A

Yes

93
Q

What forms of liver damage has black cohosh been linked with?

A

Hepatitis, liver failure, LFT derangement and various other injuries

94
Q

What is an inherent risk associated with herbal and natural products?

A

Due to their less rigorous testing, they are more prone to adulterants/contaminants